Curanex Pharmaceuticals
Tracked across 1 events · 6 articles · First seen May 18, 2026 · Last active May 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Curanex Pharmaceuticals is under investigation for potential securities fraud and unlawful business practices, which has led to a significant drop in its stock price and potential legal liabilities. The company's stock plummeted from a peak of $9.16 to $1.51 per share.
May 18, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Curanex Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard